Results 131 to 140 of about 305,335 (274)

Celebrating 20 years of open access publishing at BMC Musculoskeletal Disorders. [PDF]

BMC Musculoskelet Disord, 2020
Fitzpatrick CM, Athwal A.
europepmc   +1 more source

Open access publishing.

Ecancermedicalscience, 2011
Cairns, Linda, Russell-Edu, William
openaire   +2 more sources

The New Open Access Environment: Innovation in Research, Editing and Publishing

, 2016
Robert Eaglestone, Caroline Edwards, Jenifer Gundry, Alex Mueller, Elissa Zellinger   +4 more
openalex   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Variability in article processing charges of open-access publishing across medical specialties. [PDF]

PLoS One
Tocco EG, Mayhew MM, Mercante MG, Kuchimanchi N, Moheb ME, Shen C, Tsung A, Witt RG.   +7 more
europepmc   +1 more source

Project DEAL - Germany is leading the way in the transition to open access publishing. [PDF]

J Appl Clin Med Phys, 2020
Mills M.
europepmc   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Hurdles to open access publishing faced by authors: a scoping literature review from 2004 to 2023. [PDF]

R Soc Open Sci
Kaliuzhna N, Aydin Z, Müller P, Hauschke C.   +3 more
europepmc   +1 more source

Publishing at any cost: a cross-sectional study of the amount that medical researchers spend on open access publishing each year. [PDF]

BMJ Open, 2021
Ellingson MK, Shi X, Skydel JJ, Nyhan K, Lehman R, Ross JS, Wallach JD.   +6 more
europepmc   +1 more source